Ondansetron (zofran) QT prolonging warning

The FDA has issued an advisory to prescribers of the risk of QT prolongation with ondansetron. It should be avoided in patients with prolonged QT, and used cautiously in patients on other QT prolonging drugs (abstract)

This entry was posted in GI. Bookmark the permalink.

Comments are closed.